Company / EPS (Basic)
Royalty Pharma plc EPS (Basic) History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest EPS (Basic)
$2.54
FY2025
5-year range
$0.10 / $2.54
FY2021-FY2025
Trend
+2440.0%
vs FY2024
Sector context
#22 of 208
Health Care
What the data says
EPS (Basic) changed +2440% YoY in FY2025, a notable deviation from the 5-year average annual change of +472%.
Based on SEC 10-K filings.
2.54 in FY2025 with a 5-year CAGR of +14.0%. Top quartile in the Health Care sector.
Improved from $1.49 to $2.54 over the past 2 years.
Health Care sector context is included.
EPS (Basic) over time
Growth rates
- 3-Year CAGR
- +24.4%
- 5-Year CAGR
- +14.0%
- 10-Year CAGR
- -
Sector benchmark
Top 11% in Health CareTop 11% of 208This company $2.54 Sector average -$0.96
▼
+363.7% above sector average
Key checks
Key Insights
- In FY2025, eps (basic) increased 2440.0% year-over-year.
- Ranks #22 out of 208 companies in the Health Care sector.
- Lowest eps (basic) in the period was in FY2024.
Company context
Key Data Points
- Altman Z-Score 0.91 (distress zone, below 1.8 threshold)
- Strong profit margin: 38.0%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | EPS (Basic)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | $2.54 | +2440.0% |
| FY2024 | $0.10 | -93.3% |
| FY2023 | $1.49 | +12.9% |
| FY2022 | $1.32 | +0.0% |
| FY2021 | $1.32 | +0.0% |
| FY2020 | $1.32 | - |
| FY2019 | - | - |
| FY2018 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026